ENTO Entero Therapeutics, Inc.

Nasdaq www.enterothera.com


$ 5.11 $ -0.29 (-5.37 %)    

Wednesday, 15-Oct-2025 17:28:34 EDT
QQQ $ 602.27 $ 4.22 (0.71 %)
DIA $ 462.77 $ 0.00 (0 %)
SPY $ 665.14 $ 2.94 (0.44 %)
TLT $ 90.72 $ -0.20 (-0.22 %)
GLD $ 387.63 $ 6.60 (1.73 %)
$ 5.11
$ 5.80
$ 5.11 x 1
$ 5.75 x 78
$ 4.90 - $ 5.84
$ 0.97 - $ 5.84
300,239
na
8.12M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-01-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 10-21-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-20-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-23-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-24-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-13-2018 06-30-2018 10-Q
30 05-14-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-25-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Entero Therapeutics (NASDAQ:ENTO) didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patien...

 stock-market-today-dow-futures-slip-sp-500-rises-amid-mixed-tradeberkshire-occidental-fermi-in-focus

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices w...

 angiodynamics-globant-and-3-stocks-to-watch-heading-into-thursday

US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics.

Core News & Articles

Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler...

Core News & Articles

-SEC Filing

 top-5-biotech-stocks-with-strong-momentum

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Core News & Articles

Entero Therapeutics (NASDAQ:ENTO) reported quarterly losses of $(0.21) per share. This is a 94.56 percent increase over losses ...

Core News & Articles

Entero Therapeutics, Inc. (NASDAQ:ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the...

 us-stocks-likely-to-open-higher-trumps-tariff-clock-ticks-fed-likely-to-keep-rates-unchanged

U.S. stock futures advanced on Wednesday after ending on a mixed note on Tuesday. Futures of major benchmark indices were tradi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION